IMAX Corporation Reports Fourth Quarter And Full Year 2020 Results
Results for the fourth quarter reflect the strong performance of the IMAX network in
"As the world's only global blockbuster entertainment platform, we are encouraged to see that audiences are eager to return to the movies where the virus is under control and they feel safe, and this promising trend is reflected in our consistent financial improvement since the start of the pandemic," said IMAX CEO,
"Given strong demand for The IMAX Experience in
"As we manage through the pandemic, IMAX continues to benefit from its strong, differentiated business model and unique position in the entertainment ecosystem. Our global footprint offers access to open markets and thriving local language film industries. Our premium experience and strong brand help ensure that our passionate, engaged fans will be among the first to return to theaters. Finally, our asset-light, flexible model enables us to manage costs, capitalize on opportunities in this dynamic environment, and generate the improving financial results we posted in the fourth quarter."
IMAX reported fourth quarter 2020 revenues of
IMAX achieved positive EBITDA per Credit Facility(1) and free cash flow for the first time since the first quarter of 2020, despite capacity limitations and continued delays in the
IMAX results reflect the COVID-19 related partial closure of the Company's network as well as the inclusion of a number of notable non-cash items, including: a valuation allowance to reduce the value of deferred tax assets of
Fourth Quarter and December Year-to-Date Financial Highlights
Three Months Ended |
Year Ended |
||||||||||||||||||||||
|
|
||||||||||||||||||||||
In thousands except per share data |
2020 |
2019 |
YoY % Change |
2020 |
2019 |
YoY % Change |
|||||||||||||||||
Total Revenue |
$ |
56.0 |
$ |
124.3 |
(54.9) |
% |
$ |
137.0 |
$ |
395.7 |
(65.4) |
% |
|||||||||||
Gross Margin |
$ |
20.3 |
$ |
62.4 |
(67.4) |
% |
$ |
21.5 |
$ |
214.2 |
(89.9) |
% |
|||||||||||
Gross Margin (%) |
36.3 |
% |
50.2 |
% |
15.7 |
% |
54.1 |
% |
|||||||||||||||
Net (Loss) Income attributable to common shareholders |
$ |
(21.2) |
$ |
18.2 |
N/A |
$ |
(143.8) |
$ |
46.9 |
N/A |
|||||||||||||
Diluted Net (Loss) Income per share attributable to common shareholders |
$ |
(0.36) |
$ |
0.29 |
N/A |
$ |
(2.43) |
$ |
0.76 |
N/A |
|||||||||||||
Adjusted Net (Loss) Income attributable to common shareholders(1) |
$ |
(12.7) |
$ |
21.5 |
N/A |
$ |
(112.1) |
$ |
64.8 |
N/A |
|||||||||||||
Adjusted Net (Loss) Income per share attributable to common shareholders(1) |
$ |
(0.21) |
$ |
0.35 |
N/A |
$ |
(1.89) |
$ |
1.05 |
N/A |
|||||||||||||
Adjusted EBITDA per Credit Facility attributable to common shareholders(1) |
$ |
10.0 |
$ |
47.0 |
(78.7) |
% |
$ |
(13.1) |
$ |
149.3 |
(108.8) |
% |
|||||||||||
Adjusted EBITDA Margin attributable to common shareholders (%) (1) |
20.8 |
% |
41.7 |
% |
(50.0) |
% |
(10.8) |
% |
41.7 |
% |
(125.9) |
% |
(1) Non-GAAP Financial Measure |
Note: For the definition and reconciliations of reported results to non-GAAP financial results, please refer to the discussion of non-GAAP financial measures at the end of this earnings release. |
Fourth Quarter and December Year-to-Date Segment Results(1)
IMAX Technology Network |
IMAX Technology Sales and Maintenance |
|||||||||||||||||||||||
Revenue |
Gross Margin |
Gross |
Revenue |
Gross Margin |
Gross |
|||||||||||||||||||
4Q20 |
$ |
17.7 |
$ |
7.3 |
41.4 |
% |
$ |
36.4 |
$ |
13.6 |
37.5 |
% |
||||||||||||
4Q19 |
43.3 |
24.7 |
56.9 |
% |
77.3 |
39.5 |
51.2 |
% |
||||||||||||||||
% change |
(59.1) |
% |
(70.2) |
% |
(52.9) |
% |
(65.5) |
% |
||||||||||||||||
YTD 4Q20 |
$ |
46.1 |
$ |
4.2 |
9.2 |
% |
$ |
79.8 |
$ |
28.0 |
35.1 |
% |
||||||||||||
YTD 4Q19 |
197.4 |
127.0 |
64.3 |
% |
179.9 |
86.4 |
48.0 |
% |
||||||||||||||||
% change |
(76.6) |
% |
(96.7) |
% |
(55.6) |
% |
(67.6) |
% |
_____________ |
(1) Please refer to the Company's Form 10-K for the period ended |
IMAX Technology Network
- IMAX Technology Network revenues decreased 59.1% to
$17.7 million in the fourth quarter of 2020, compared to$43.3 million in the prior-year period. The partial closure of the Company's network through the quarter and the release of fewer films, both a result of the COVID-19 global pandemic, drove the decline in gross box office and revenue. - Gross margin for the IMAX Technology Network declined 70.2% to
$7.3 million in the fourth quarter of 2020. The decline was driven by lower segment revenue and ongoing fixed costs associated with the installed IMAX network.
IMAX Technology Sales and Maintenance
- IMAX Technology Sales and Maintenance revenues decreased 52.9% to
$36.4 million in the fourth quarter of 2020, compared with$77.3 million in the prior year period. The decline in revenue was the result of installing 12 fewer sales-type-lease and 5 fewer hybrid systems in the quarter. - Total gross margin for IMAX Technology Sales and Maintenance was
$13.6 million compared to$39.5 million in the prior year period. The decrease in gross margin was the result of lower sales activity and revenue in the quarter.
Cash Balances and Outstanding Debt
Total cash and cash equivalents as of
Share Count and Capital Return
The weighted average diluted shares outstanding at the end of the fourth quarter of 2020 declined 4.4% to 58.9 million, compared to 61.5 million in the fourth quarter of 2019, due primarily to share repurchase activity during the twelve-month period. During the fourth quarter of 2020, the Company did not repurchase any stock. A total of
Supplemental Materials
For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.
Investor Relations Website and Social Media
On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag.
The Company may post additional information on the Company's corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases,
Conference Call
The Company will host a conference call today at
About
IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.
IMAX is headquartered in
IMAX®, IMAX® Dome, IMAX® 3D, IMAX® 3D Dome, Experience It In IMAX®, The IMAX Experience®, An IMAX Experience®, An IMAX 3D Experience®, IMAX DMR®, DMR®, IMAX nXos® and Films to the Fullest®, are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Instagram (https://www.instagram.com/imax), Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).
For additional information please contact:
Investors: |
Media: |
|
|
|
|
212-821-0187 |
212-821-0102 |
Forward-Looking Statements
This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), plans and references to the future success of
Primary Reporting Groups
The Company has the following reportable segments: (i) IMAX DMR; (ii) Joint Revenue Sharing Arrangements; (iii) IMAX Systems, (iv) IMAX Maintenance; (v) Other Theater Business; (vi) New Business Initiatives; (vii) Film Distribution; and (viii) Film Post-Production. The Company organizes its reportable segments into the following four categories, identified by the nature of the product sold or service provided:
(i) |
IMAX Technology Network, which earns revenue based on contingent box office receipts and includes the IMAX DMR segment and contingent rent from the Joint Revenue Sharing Arrangement ("JRSA") segment; |
(ii) |
IMAX Technology Sales and Maintenance, which includes results from the IMAX Systems, IMAX Maintenance and Other Theater Business segments, as well as fixed revenues from the JRSA segment; |
(iii) |
New Business Initiatives, which is a segment that includes activities related to the exploration of new lines of business and new initiatives outside of the Company's core business; and |
(iv) |
Film Distribution and Post-Production, which includes activities related to the licensing of film content, the distribution of films primarily for the Company's institutional theater partners (through the Film Distribution segment) and the provision of film post-production and quality control services (through the Film Post-Production segment). |
Signings and Installations |
|||||||||
Twelve Months Ended |
|||||||||
Theater System Signings: |
2020 |
2019 |
|||||||
New IMAX Theater Systems |
|||||||||
Sales and sales-type lease arrangements |
28 |
49 |
|||||||
Hybrid joint revenue sharing lease arrangements |
18 |
48 |
|||||||
Traditional joint revenue sharing arrangements |
2 |
7 |
|||||||
Total new IMAX Theater Systems |
48 |
104 |
|||||||
Upgrades of IMAX Theater Systems |
17 |
39 |
|||||||
Total IMAX Theater System signings |
65 |
143 |
|||||||
Twelve Months Ended |
|||||||||
Theater System Installations: |
2020 |
2019 |
|||||||
New IMAX Theater Systems |
|||||||||
Sales and sales-type lease arrangements |
27 |
55 |
|||||||
Hybrid joint revenue sharing lease arrangements |
5 |
20 |
|||||||
Traditional joint revenue sharing arrangements |
23 |
54 |
|||||||
Total new IMAX Theater Systems |
55 |
129 |
|||||||
Upgrades of IMAX Theater Systems |
16 |
57 |
|||||||
Total IMAX Theater System installations |
71 |
186 |
|||||||
Twelve Months Ended |
|||||||||
Theater Sales Backlog: |
2020 |
2019 |
|||||||
Sales and sales-type lease arrangements |
185 |
178 |
|||||||
Hybrid joint revenue sharing lease arrangements |
147 |
140 |
|||||||
Traditional joint revenue sharing lease arrangements |
195 |
(1) |
213 |
(1) |
|||||
|
527 |
(2) |
531 |
(3) |
|||||
Twelve Months Ended |
|||||||||
Theater Network: |
2020 |
2019 |
|||||||
|
|||||||||
Sales and sales-type lease arrangements |
672 |
659 |
|||||||
Hybrid joint revenue sharing lease arrangements |
140 |
139 |
|||||||
Traditional joint revenue sharing lease arrangements |
750 |
731 |
|||||||
|
1,562 |
1,529 |
|||||||
|
12 |
14 |
|||||||
|
76 |
81 |
|||||||
|
1,650 |
1,624 |
_____________ |
(1) Includes 46 IMAX Theater Systems where the customer has the option to convert from a joint revenue sharing arrangement to a sales arrangement (2019 — 47). |
(2) Includes 148 new IMAX with Laser projection system configurations and 95 upgrades of existing locations to IMAX with Laser projection system configurations. |
(3) Includes 144 new IMAX with Laser projection system configurations and 92 upgrades of existing locations to IMAX with Laser projection system configurations. |
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||
(In thousands of |
||||||||||||||||
Three Months Ended |
||||||||||||||||
|
Year Ended |
|||||||||||||||
(Unaudited) |
|
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Revenues |
||||||||||||||||
Technology sales |
$ |
25,626 |
$ |
61,616 |
$ |
49,728 |
$ |
118,245 |
||||||||
Image enhancement and maintenance services |
20,209 |
43,570 |
59,318 |
188,547 |
||||||||||||
Technology rentals |
7,534 |
16,286 |
17,841 |
77,961 |
||||||||||||
Finance income |
2,621 |
2,807 |
10,116 |
10,911 |
||||||||||||
55,990 |
124,279 |
137,003 |
395,664 |
|||||||||||||
Costs and expenses applicable to revenues |
||||||||||||||||
Technology sales |
17,533 |
30,513 |
33,170 |
63,627 |
||||||||||||
Image enhancement and maintenance services |
11,549 |
21,970 |
53,598 |
88,175 |
||||||||||||
Technology rentals |
6,595 |
9,437 |
28,695 |
29,690 |
||||||||||||
35,677 |
61,920 |
115,463 |
181,492 |
|||||||||||||
Gross margin |
20,313 |
62,359 |
21,540 |
214,172 |
||||||||||||
Selling, general and administrative expenses |
25,238 |
34,189 |
108,485 |
123,456 |
||||||||||||
Research and development |
1,056 |
1,486 |
5,618 |
5,203 |
||||||||||||
Amortization of intangibles |
1,380 |
1,391 |
5,394 |
4,955 |
||||||||||||
Credit loss expense |
3,026 |
473 |
18,608 |
2,430 |
||||||||||||
Asset impairments |
- |
- |
1,151 |
- |
||||||||||||
Legal judgment and arbitration awards |
4,105 |
- |
4,105 |
- |
||||||||||||
Exit costs, restructuring charges and associated impairments |
- |
- |
- |
850 |
||||||||||||
(Loss) income from operations |
(14,492) |
24,820 |
(121,821) |
77,278 |
||||||||||||
(Loss) gain in fair value of investments |
(1,142) |
2,026 |
(2,081) |
(517) |
||||||||||||
Retirement benefits non-service expense |
(168) |
(257) |
(600) |
(737) |
||||||||||||
Interest income |
546 |
473 |
2,388 |
2,105 |
||||||||||||
Interest expense |
(2,390) |
(987) |
(7,010) |
(2,793) |
||||||||||||
(Loss) income before taxes |
(17,646) |
26,075 |
(129,124) |
75,336 |
||||||||||||
Income tax expense |
(1,898) |
(4,782) |
(26,504) |
(16,768) |
||||||||||||
Equity in (losses) gains of investees, net of tax |
- |
59 |
(1,858) |
3 |
||||||||||||
Net (loss) income |
(19,544) |
21,352 |
(157,486) |
58,571 |
||||||||||||
Net loss (income) attributable to non-controlling interests |
(1,701) |
(3,181) |
13,711 |
(11,705) |
||||||||||||
Net (loss) income attributable to common shareholders |
$ |
(21,245) |
$ |
18,171 |
$ |
(143,775) |
$ |
46,866 |
||||||||
Net (loss) income per share attributable to common shareholders basic and diluted: |
||||||||||||||||
Net (loss) income per share — basic and diluted |
$ |
(0.36) |
$ |
0.29 |
$ |
(2.43) |
$ |
0.76 |
||||||||
Weighted average number of shares outstanding (000's): |
||||||||||||||||
Basic |
58,872 |
61,228 |
59,237 |
61,310 |
||||||||||||
Fully Diluted |
58,872 |
61,542 |
59,237 |
61,489 |
||||||||||||
Additional Disclosure: |
||||||||||||||||
Depreciation and amortization(1) |
$ |
12,312 |
$ |
17,987 |
$ |
53,606 |
$ |
63,487 |
||||||||
(1) Includes |
|
|||||||
CONSOLIDATED BALANCE SHEETS |
|||||||
In accordance with United States Generally Accepted Accounting Principles |
|||||||
(In thousands of dollars, except share amounts) |
|||||||
As of |
|||||||
2020 |
2019 |
||||||
Assets |
|||||||
Cash and cash equivalents |
$ |
317,379 |
$ |
109,484 |
|||
Accounts receivable, net of allowance for credit losses |
56,300 |
99,513 |
|||||
Financing receivables, net of allowance for credit losses |
131,810 |
128,038 |
|||||
Variable consideration receivable, net of allowance for credit losses |
40,526 |
40,040 |
|||||
Inventories |
39,580 |
42,989 |
|||||
Prepaid expenses |
10,420 |
10,237 |
|||||
Film assets |
5,777 |
17,921 |
|||||
Property, plant and equipment, net of accumulated depreciation |
277,397 |
306,849 |
|||||
Investment in equity securities |
13,633 |
15,685 |
|||||
Other assets |
21,673 |
25,034 |
|||||
Deferred income tax assets |
17,983 |
23,905 |
|||||
Other intangible assets, net of accumulated amortization |
26,245 |
30,347 |
|||||
|
39,027 |
39,027 |
|||||
Total assets |
$ |
997,750 |
$ |
889,069 |
|||
Liabilities |
|||||||
Bank indebtedness, net of unamortized debt issuance costs |
$ |
305,676 |
$ |
18,229 |
|||
Accounts payable |
20,837 |
20,414 |
|||||
Accrued and other liabilities |
99,354 |
112,779 |
|||||
Deferred revenue |
87,982 |
94,552 |
|||||
Deferred income tax liabilities |
19,134 |
— |
|||||
Total liabilities |
532,983 |
245,974 |
|||||
Commitments and contingencies |
|||||||
Non-controlling interests |
759 |
5,908 |
|||||
Shareholders' equity |
|||||||
Capital stock common shares — no par value. Authorized — unlimited number. |
|||||||
58,921,731 issued and 58,921,008 outstanding ( |
407,031 |
423,386 |
|||||
Less: |
(11) |
(4,038) |
|||||
Other equity |
180,330 |
171,789 |
|||||
Accumulated deficit |
(202,849) |
(40,253) |
|||||
Accumulated other comprehensive income (loss) |
988 |
(3,190) |
|||||
Total shareholders' equity attributable to common shareholders |
385,489 |
547,694 |
|||||
Non-controlling interests |
78,519 |
89,493 |
|||||
Total shareholders' equity |
464,008 |
637,187 |
|||||
Total liabilities and shareholders' equity |
$ |
997,750 |
$ |
889,069 |
|
|||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||||
(In thousands of dollars) |
|||||||||
Years Ended |
|||||||||
2020 |
2019 |
||||||||
Cash provided by (used in): |
|||||||||
Operating Activities |
|||||||||
Net (loss) income |
$ |
(157,486) |
$ |
58,571 |
|||||
Adjustments to reconcile net (loss) income to cash from operations: |
|||||||||
Depreciation and amortization |
53,606 |
63,487 |
|||||||
Credit loss expense |
18,608 |
2,430 |
|||||||
Write-downs |
17,729 |
4,376 |
|||||||
Deferred income tax expense |
23,618 |
6,762 |
|||||||
Share-based and other non-cash compensation |
22,038 |
23,570 |
|||||||
Unrealized foreign currency exchange (gain) loss |
(1,355) |
32 |
|||||||
Loss in fair value of investments |
2,081 |
517 |
|||||||
Equity in losses (income) of investees |
1,858 |
(3) |
|||||||
Changes in assets and liabilities: |
— |
||||||||
Accounts receivable |
33,597 |
(8,621) |
|||||||
Inventories |
1,637 |
1,942 |
|||||||
Film assets |
(7,665) |
(23,437) |
|||||||
Deferred revenue |
(6,637) |
(12,242) |
|||||||
Changes in other operating assets and liabilities |
(24,640) |
(27,008) |
|||||||
Net cash (used in) provided by operating activities |
(23,011) |
90,376 |
|||||||
Investing Activities |
|||||||||
Purchase of property, plant and equipment |
(697) |
(7,421) |
|||||||
Investment in equipment for joint revenue sharing arrangements |
(6,654) |
(40,489) |
|||||||
Acquisition of other intangible assets |
(1,904) |
(2,931) |
|||||||
Investment in equity securities |
— |
(15,153) |
|||||||
Net cash used in investing activities |
(9,255) |
(65,994) |
|||||||
Financing Activities |
|||||||||
Increase in revolving credit facility borrowings |
287,610 |
35,000 |
|||||||
Repayment of revolving credit facility borrowings |
— |
(55,000) |
|||||||
Credit facility amendment fees paid |
(1,073) |
— |
|||||||
Settlement of restricted share units and options |
(3,075) |
(9,795) |
|||||||
|
(11) |
(4,038) |
|||||||
Repurchase of common shares, IMAX China |
(1,534) |
(19,162) |
|||||||
Taxes withheld and paid on employee stock awards vested |
(512) |
(590) |
|||||||
Common shares issued - stock options exercised |
— |
2,404 |
|||||||
Repurchase of common shares |
(36,624) |
(2,659) |
|||||||
Issuance of subsidiary shares to non-controlling interests (net of return on capital) |
— |
1,106 |
|||||||
Dividends paid to non-controlling interests |
(4,214) |
(4,384) |
|||||||
Net cash provided by (used in) financing activities |
240,567 |
(57,118) |
|||||||
Effects of exchange rate changes on cash |
(406) |
630 |
|||||||
Increase (decrease) in cash and cash equivalents during year |
207,895 |
(32,106) |
|||||||
Cash and cash equivalents, beginning of year |
109,484 |
141,590 |
|||||||
Cash and cash equivalents, end of year |
$ |
317,379 |
$ |
109,484 |
Three Months Ended |
Year Ended |
||||||||||||||
|
|
||||||||||||||
2020 |
2019 |
2020 |
2019 |
||||||||||||
Revenue |
|||||||||||||||
IMAX Technology Network |
|||||||||||||||
IMAX DMR |
$ |
10,204 |
$ |
26,857 |
$ |
28,265 |
$ |
120,765 |
|||||||
Joint revenue sharing arrangements, contingent rent |
7,534 |
16,484 |
17,841 |
76,673 |
|||||||||||
17,738 |
43,341 |
46,106 |
197,438 |
||||||||||||
IMAX Technology Sales and Maintenance |
|||||||||||||||
IMAX Systems |
26,381 |
56,817 |
54,055 |
107,321 |
|||||||||||
Joint revenue sharing arrangements, fixed fees |
860 |
4,489 |
2,056 |
11,014 |
|||||||||||
IMAX Maintenance |
8,774 |
13,336 |
21,999 |
53,151 |
|||||||||||
Other Theater Business |
405 |
2,624 |
1,666 |
8,390 |
|||||||||||
36,420 |
77,266 |
79,776 |
179,876 |
||||||||||||
New Business Initiatives |
738 |
846 |
2,226 |
2,754 |
|||||||||||
Film Distribution and Post-Production |
1,178 |
2,419 |
8,719 |
12,210 |
|||||||||||
56,074 |
123,872 |
136,827 |
392,278 |
||||||||||||
Other |
(84) |
407 |
176 |
3,386 |
|||||||||||
Total revenues |
$ |
55,990 |
$ |
124,279 |
$ |
137,003 |
$ |
395,664 |
|||||||
Gross Margin (Margin Loss) |
|||||||||||||||
IMAX Technology Network |
|||||||||||||||
IMAX DMR(1) |
$ |
6,239 |
$ |
16,990 |
$ |
13,731 |
$ |
78,592 |
|||||||
Joint revenue sharing arrangements, contingent rent(1) |
1,110 |
7,669 |
(9,500) |
48,446 |
|||||||||||
7,349 |
24,659 |
4,231 |
127,038 |
||||||||||||
IMAX Technology Sales and Maintenance |
|||||||||||||||
IMAX Systems (1) |
10,319 |
31,445 |
24,816 |
58,168 |
|||||||||||
Joint revenue sharing arrangements, fixed fees(1) |
419 |
1,312 |
529 |
2,613 |
|||||||||||
IMAX Maintenance |
3,423 |
5,964 |
3,068 |
23,010 |
|||||||||||
Other Theater Business |
(515) |
803 |
(438) |
2,624 |
|||||||||||
13,646 |
39,524 |
27,975 |
86,415 |
||||||||||||
New Business Initiatives |
633 |
665 |
1,878 |
2,106 |
|||||||||||
Film Distribution and Post-Production (1)(2) |
(806) |
(1,745) |
(10,198) |
(1,262) |
|||||||||||
20,822 |
63,103 |
23,886 |
214,297 |
||||||||||||
Other |
(509) |
(744) |
(2,346) |
(125) |
|||||||||||
Total Segment Margin |
$ |
20,313 |
$ |
62,359 |
$ |
21,540 |
$ |
214,172 |
__________________ |
(1) IMAX DMR segment margins include marketing cost of |
(2) Film Distribution margins were significantly influenced by impairment loss recorded of |
NON-GAAP FINANCIAL MEASURES
(in thousands of
In this release, the Company presents adjusted net (loss) income attributable to common shareholders and adjusted net (loss) income attributable to common shareholders per diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin, and free cash flow as supplemental measures of the Company's performance, which are not recognized under
The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net (loss) income attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.
A reconciliation from net (loss) income attributable to common shareholders and the associated per share amounts to adjusted net (loss) income attributable to common shareholders and adjusted net (loss) income attributable to common shareholders per diluted share is presented in the table below. Net (loss) income attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests. Accordingly, beginning in the first quarter of 2020, the Company updated its reconciliations of these non-GAAP financial measures to reflect this approach.
In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as such term is defined in the Credit Agreement, and which is referred to herein as "Adjusted EBITDA per Credit Facility." As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Adjusted EBITDA per Credit Facility measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its Credit Agreement requirements when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results.
EBITDA is defined as net income or loss excluding (i) interest expense, net of interest income; (ii) income tax expense or benefit; and (iii) depreciation and amortization, including film asset amortization. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) gain or loss in fair value of investments; (iii) write-downs, net of recoveries, including asset impairments and credit loss expense; (iv) legal judgment and arbitration award; (v) gain or loss from equity accounted investments; and (vi) exit costs, restructuring charges and associated impairments.
A reconciliation of net loss attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net loss attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests. Accordingly, beginning in the first quarter of 2020, the Company updated its reconciliations of these non-GAAP financial measures to reflect this approach.
Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the condensed consolidated statements of cash flows). Cash provided by operating activities consist of net (loss) income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.
These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.
Adjusted EBITDA per Credit Facility |
|||||||||||||||||||||||||||||
For the Three Months Ended |
For the Three Months Ended |
||||||||||||||||||||||||||||
Attributable to Non-controlling |
Less: |
Attributable to Non-controlling |
Less: |
||||||||||||||||||||||||||
Interests and |
Attributable to |
Attributable to |
Interests and |
Attributable to |
Attributable to |
||||||||||||||||||||||||
Common |
Non-controlling |
Common |
Common |
Non-controlling |
Common |
||||||||||||||||||||||||
Shareholders |
Interests |
Shareholders |
Shareholders |
Interests |
Shareholders |
||||||||||||||||||||||||
(In thousands of |
|||||||||||||||||||||||||||||
Reported net (loss) income |
$ |
(19,544) |
$ |
1,701 |
$ |
(21,245) |
$ |
21,352 |
$ |
3,181 |
$ |
18,171 |
|||||||||||||||||
Add (subtract): |
|||||||||||||||||||||||||||||
Income tax expense |
1,898 |
717 |
1,181 |
4,782 |
858 |
3,924 |
|||||||||||||||||||||||
Interest expense, net of interest income |
1,537 |
(90) |
1,627 |
381 |
(108) |
489 |
|||||||||||||||||||||||
Depreciation and amortization, including film asset amortization |
12,312 |
1,099 |
11,213 |
17,987 |
1,266 |
16,721 |
|||||||||||||||||||||||
EBITDA |
$ |
(3,797) |
$ |
3,427 |
$ |
(7,224) |
$ |
44,502 |
$ |
5,197 |
$ |
39,305 |
|||||||||||||||||
Share-based and other non-cash compensation |
5,693 |
226 |
5,467 |
6,173 |
143 |
6,030 |
|||||||||||||||||||||||
Loss (gain) in fair value of investments |
1,142 |
353 |
789 |
(2,026) |
(642) |
(1,384) |
|||||||||||||||||||||||
Write-downs, including asset impairments and credit loss expense |
7,416 |
533 |
6,883 |
3,822 |
759 |
3,063 |
|||||||||||||||||||||||
Legal judgment and arbitration awards(4) |
4,105 |
— |
4,105 |
||||||||||||||||||||||||||
Gain from equity accounted investments |
— |
— |
— |
(59) |
— |
(59) |
|||||||||||||||||||||||
Adjusted EBITDA per Credit Facility |
$ |
14,559 |
$ |
4,539 |
$ |
10,020 |
$ |
52,412 |
$ |
5,457 |
$ |
46,955 |
|||||||||||||||||
Revenues attributable to common shareholders(2) |
55,990 |
7,926 |
48,064 |
124,279 |
11,644 |
112,635 |
|||||||||||||||||||||||
Adjusted EBITDA margin attributable to common shareholders |
26.0 |
% |
57.3 |
% |
20.8 |
% |
42.2 |
% |
46.9 |
% |
41.7 |
% |
|||||||||||||||||
For the Twelve Months Ended |
For the Twelve Months Ended |
||||||||||||||||||||||||||||
Attributable to Non-controlling |
Less: |
Attributable to Non-controlling |
Less: |
||||||||||||||||||||||||||
Interests and |
Attributable to |
Attributable to |
Interests and |
Attributable to |
Attributable to |
||||||||||||||||||||||||
Common |
Non-controlling |
Common |
Common |
Non-controlling |
Common |
||||||||||||||||||||||||
Shareholders |
Interests |
Shareholders |
Shareholders |
Interests |
Shareholders |
||||||||||||||||||||||||
(In thousands of |
|||||||||||||||||||||||||||||
Reported net (loss) income |
$ |
(157,486) |
$ |
(13,711) |
$ |
(143,775) |
$ |
58,571 |
$ |
11,705 |
$ |
46,866 |
|||||||||||||||||
Add (subtract): |
|||||||||||||||||||||||||||||
Income tax expense |
26,504 |
5,408 |
21,096 |
16,768 |
3,625 |
13,143 |
|||||||||||||||||||||||
Interest expense, net of interest income |
3,720 |
(370) |
4,090 |
423 |
(524) |
947 |
|||||||||||||||||||||||
Depreciation and amortization, including film asset amortization |
53,606 |
4,570 |
49,036 |
63,487 |
5,033 |
58,454 |
|||||||||||||||||||||||
EBITDA |
$ |
(73,656) |
$ |
(4,103) |
$ |
(69,553) |
$ |
139,249 |
$ |
19,839 |
$ |
119,410 |
|||||||||||||||||
Share-based and other non-cash compensation |
22,038 |
968 |
21,070 |
23,570 |
617 |
22,953 |
|||||||||||||||||||||||
Loss in fair value of investments |
2,081 |
631 |
1,450 |
517 |
165 |
352 |
|||||||||||||||||||||||
Write-downs, including asset impairments and credit loss expense |
36,337 |
8,364 |
27,973 |
6,806 |
1,040 |
5,766 |
|||||||||||||||||||||||
Legal judgment and arbitration awards(4) |
4,105 |
— |
4,105 |
— |
— |
— |
|||||||||||||||||||||||
Loss from equity accounted investments |
1,858 |
— |
1,858 |
(3) |
— |
(3) |
|||||||||||||||||||||||
Exit costs, restructuring charges and associated impairments |
— |
— |
— |
850 |
— |
850 |
|||||||||||||||||||||||
Adjusted EBITDA per Credit Facility |
$ |
(7,237) |
$ |
5,860 |
$ |
(13,097) |
$ |
170,989 |
$ |
21,661 |
$ |
149,328 |
|||||||||||||||||
Revenues attributable to common shareholders(2) |
137,003 |
15,767 |
121,236 |
395,664 |
37,611 |
358,053 |
|||||||||||||||||||||||
Adjusted EBITDA margin attributable to common shareholders |
-5.3 |
% |
37.2 |
% |
-10.8 |
% |
43.2 |
% |
57.6 |
% |
41.7 |
% |
____________ |
(1) Senior Secured Net Leverage Ratio calculated using twelve months ended Adjusted EBITDA per Credit Facility. During the second quarter of 2020, the Company entered into the Amendment to the Credit Facility Agreement which provides for, among other things, the suspension of the Senior Secured Net Leverage Ratio financial covenant through the first quarter of 2021. |
(2) |
||||||||||||||||||||||||||||||||||||||
Three months ended |
Three months ended |
12 months ended |
12 months ended |
|||||||||||||||||||||||||||||||||||
Total revenues |
$ |
55,990 |
$ |
124,279 |
$ |
137,003 |
$ |
395,664 |
||||||||||||||||||||||||||||||
|
$ |
26,323 |
$ |
38,481 |
$ |
52,331 |
$ |
124,294 |
||||||||||||||||||||||||||||||
Non-controlling interest ownership percentage(3) |
30.11 |
% |
30.26 |
% |
30.13 |
% |
30.26 |
% |
||||||||||||||||||||||||||||||
Deduction for non-controlling interest share of revenues |
(7,926) |
(11,644) |
(15,767) |
(37,611) |
||||||||||||||||||||||||||||||||||
Revenues attributable to common shareholders |
$ |
48,064 |
$ |
112,635 |
$ |
121,236 |
$ |
358,053 |
(2) |
Weighted average ownership percentage for change in non-controlling interest share |
(3) |
Includes a |
Adjusted Net (Loss) Income Attributable to Common Shareholders and Adjusted Diluted Per Share Calculations |
|||||||||||||||
Three Months Ended |
Three Months Ended |
||||||||||||||
|
|
||||||||||||||
(In thousands of |
Net Loss |
Diluted EPS |
Net Income |
Diluted EPS |
|||||||||||
Net (loss) income attributable to common shareholders |
$ |
(21,245) |
$ |
(0.36) |
$ |
18,171 |
$ |
0.29 |
|||||||
Adjustments(1): |
|||||||||||||||
Share-based compensation |
5,296 |
0.09 |
5,770 |
0.09 |
|||||||||||
COVID-19 government relief benefits(2) |
(1,880) |
(0.03) |
— |
— |
|||||||||||
Legal judgment and arbitration awards(3) |
4,105 |
0.07 |
— |
— |
|||||||||||
Exit costs, restructuring charges and associated impairments |
— |
— |
— |
— |
|||||||||||
Loss (gain) in fair value of investments |
789 |
0.01 |
(1,409) |
(0.02) |
|||||||||||
Tax impact on items listed above(4) |
(46) |
— |
(1,063) |
(0.01) |
|||||||||||
Income taxes resulting from management's decision to no longer indefinitely reinvest the historical earnings of certain foreign subsidiaries |
330 |
0.01 |
— |
— |
|||||||||||
Adjusted net (loss) income(1) |
$ |
(12,651) |
$ |
(0.21) |
$ |
21,469 |
$ |
0.35 |
|||||||
Weighted average basic shares outstanding |
58,872 |
61,228 |
|||||||||||||
Weighted average diluted shares outstanding |
58,872 |
61,542 |
______________ |
|
(1) |
Reflects amounts attributable to common shareholders. |
(2) |
The Company recognized |
(3) |
Includes a |
(4) |
For the year ended |
Year Ended |
Year Ended |
||||||||||||||
|
|
||||||||||||||
(In thousands of |
Net Loss |
Diluted EPS |
Net Income |
Diluted EPS |
|||||||||||
Net (loss) income attributable to common shareholders |
$ |
(143,775) |
$ |
(2.43) |
$ |
46,866 |
$ |
0.76 |
|||||||
Adjustments(1): |
|||||||||||||||
Share-based compensation |
20,558 |
0.35 |
22,236 |
0.36 |
|||||||||||
COVID-19 government relief benefits(2) |
(7,115) |
(0.12) |
— |
— |
|||||||||||
Legal judgment and arbitration awards(3) |
4,105 |
0.07 |
— |
— |
|||||||||||
Exit costs, restructuring charges and associated impairments |
— |
— |
850 |
0.01 |
|||||||||||
Loss in the fair value of investments |
1,450 |
0.02 |
333 |
0.01 |
|||||||||||
Tax impact on items listed above(4) |
(630) |
(0.01) |
(5,500) |
(0.09) |
|||||||||||
Income taxes resulting from management's decision to no longer indefinitely reinvest the historical earnings of certain foreign subsidiaries |
13,344 |
0.23 |
— |
— |
|||||||||||
Adjusted net (loss) income(1) |
$ |
(112,063) |
$ |
(1.89) |
$ |
64,785 |
$ |
1.05 |
|||||||
Weighted average basic shares outstanding |
59,237 |
61,310 |
|||||||||||||
Weighted average diluted shares outstanding |
59,237 |
61,489 |
________________ |
|
(1) |
Reflects amounts attributable to common shareholders. |
(2) |
The Company recognized |
(3) |
Includes a |
(4) |
For the year ended |
Free Cash Flow |
|||||||||
Three Months Ended |
Twelve Months Ended |
||||||||
|
|
||||||||
Net cash provided by (used in) operating activities |
$ |
7,807 |
$ |
(23,011) |
|||||
Net cash used in investing activities |
(1,647) |
(9,255) |
|||||||
Free cash flow |
$ |
6,160 |
$ |
(32,266) |
View original content to download multimedia:http://www.prnewswire.com/news-releases/imax-corporation-reports-fourth-quarter-and-full-year-2020-results-301240744.html
SOURCE